 <h1>Angiomax Side Effects</h1><p class="drug-subtitle"><b>Generic Name:</b> <i>bivalirudin</i></p><ul class="ddc-anchor-links"><li>Consumer</li>
<li>Professional</li></ul><p class="ddc-notification"><b>Note:</b> This document contains side effect information about bivalirudin. Some of the dosage forms listed on this page <em>may not</em> apply to the brand name Angiomax.</p><h2 class="ddc-anchor-offset" id="consumer">For the Consumer</h2><p><i>Applies to bivalirudin: intravenous powder for solution</i></p><h3>Side effects requiring immediate medical attention</h3><p>Along with its needed effects, bivalirudin (the active ingredient contained in Angiomax) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.</p><p>
<i>Check with your doctor or nurse immediately</i> if any of the following side effects occur while taking bivalirudin:</p><p>
<i>More common</i>
</p><ul>
<li>Abdominal pain or swelling</li>
<li>arm, back, or jaw pain</li>
<li>black, tarry stools</li>
<li>blood in the eyes</li>
<li>blood in the urine</li>
<li>blurred vision</li>
<li>bruising or purple areas on the skin</li>
<li>chest pain or discomfort</li>
<li>chest tightness or heaviness</li>
<li>confusion</li>
<li>coughing up blood</li>
<li>decreased alertness</li>
<li>dizziness, faintness, or lightheadedness when getting up from a lying or sitting position suddenly</li>
<li>headache</li>
<li>joint pain or swelling</li>
<li>nausea</li>
<li>nervousness</li>
<li>nosebleeds</li>
<li>pounding in the ears</li>
<li>shortness of breath</li>
<li>slow, fast, or irregular heartbeat</li>
<li>sweating</li>
<li>unusual tiredness or weakness</li>
</ul><p>
<i>Less common</i>
</p><ul>
<li>Decrease in frequency of urination</li>
<li>decrease in urine volume</li>
<li>difficulty in passing urine (dribbling)</li>
<li>lightheadedness or fainting</li>
<li>painful urination</li>
</ul><p>
<i>Rare</i>
</p><ul>
<li>Blue lips and fingernails</li>
<li>changes in skin color</li>
<li>cold hands and feet</li>
<li>cough or hoarseness</li>
<li>coughing that sometimes produces a pink frothy sputum</li>
<li>difficult, fast, noisy breathing, sometimes with wheezing</li>
<li>fever or chills</li>
<li>increased blood pressure</li>
<li>increased thirst</li>
<li>loss of appetite</li>
<li>lower back or side pain</li>
<li>pain, redness, or swelling in the arm or leg</li>
<li>pale skin</li>
<li>paralysis of the face</li>
<li>rapid, shallow breathing</li>
<li>severe numbness, especially on one side of the face or body</li>
<li>swelling in the legs and ankles</li>
<li>swelling of the face, fingers, or lower legs</li>
<li>troubled breathing</li>
<li>vomiting</li>
<li>weight gain</li>
</ul><p>
<i>Incidence not known</i>
</p><ul>
<li>Bleeding gums</li>
<li>difficulty in swallowing</li>
<li>hives</li>
<li>increased menstrual flow or vaginal bleeding</li>
<li>irritation</li>
<li>itching</li>
<li>joint stiffness</li>
<li>pains in the chest, groin, or legs, especially calves of legs</li>
<li>paralysis</li>
<li>prolonged bleeding from cuts</li>
<li>rash</li>
<li>red or dark brown urine</li>
<li>redness of the skin</li>
<li>severe headaches of sudden onset</li>
<li>sudden loss of coordination</li>
<li>sudden onset of shortness of breath for no apparent reason</li>
<li>sudden onset of slurred speech</li>
<li>sudden vision changes</li>
<li>swelling of the eyelids, lips, hands, or feet</li>
<li>wheezing</li>
</ul><h3>Side effects not requiring immediate medical attention</h3><p>Some side effects of bivalirudin may occur that usually <b>do not need medical attention</b>. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.</p><p>Check with your health care professional if any of the following side effects <b>continue or are bothersome</b> or if you have any questions about them:</p><p>
<i>More common</i>
</p><ul>
<li>Fear or nervousness</li>
<li>pain where the needle is placed</li>
<li>pelvic pain</li>
<li>sleeplessness</li>
<li>trouble sleeping</li>
<li>unable to sleep</li>
</ul><p>
<i>Less common</i>
</p><ul>
<li>Acid or sour stomach</li>
<li>belching</li>
<li>heartburn</li>
<li>indigestion</li>
<li>stomach discomfort, upset, or pain</li>
</ul><p>
<!-- end intravenous powder for solution --><div class="related-links"><svg aria-hidden="true" class="ddc-icon ddc-icon-info" focusable="false" height="22" viewbox="0 0 24 24" width="22" xmlns="http://www.w3.org/2000/svg"><path d="M14 2H6c-1.1 0-1.99.9-1.99 2L4 20c0 1.1.89 2 1.99 2H18c1.1 0 2-.9 2-2V8l-6-6zm2 16H8v-2h8v2zm0-4H8v-2h8v2zm-3-5V3.5L18.5 9H13z"></path></svg> <span>Managing side effects <span class="ddc-text-nowrap">(general information)</span></span></div>
<h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to bivalirudin: intravenous powder for injection, intravenous solution</i></p><h3>Cardiovascular</h3><p><b>Common</b> (1% to 10%): Atrial fibrillation, ventricular tachycardia, angina pectoris, bradycardia, hypertension, hypotension, chest pain</p>
<p><b>Rare</b> (less than 0.1%): Myocardial infarction, cardiac tamponade, pericardial hemorrhage, coronary artery thrombosis, coronary stent thrombosis (including reports with fatal outcome), arteriovenous fistula, catheter thrombosis, vascular pseudoaneurysm </p>
<p><b>Postmarketing reports</b>: Cardiac tamponade, ventricular fibrillation<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Uncommon</b> (0.1% to 1%): Epistaxis, hemoptysis, pharyngeal hemorrhage</p>
<p><b>Rare</b> (less than 0.1%): Pulmonary hemorrhage, dyspnea<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Uncommon</b> (0.1% to 1%): Rash, urticaria<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Common</b> (1% to 10%): Nausea, vomiting, dyspepsia</p>
<p><b>Uncommon</b> (0.1% to 1%): GI hemorrhage (i.e., hematemesis, melena, esophageal hemorrhage, anal hemorrhage), retroperitoneal hemorrhage, gingival hemorrhage</p>
<p><b>Rare</b> (less than 0.1%): Retroperitoneal hematoma<sup>[Ref]</sup></p><h3>Genitourinary</h3><p><b>Uncommon</b> (0.1% to 1%): Hematuria<sup>[Ref]</sup></p><h3>Hematologic</h3><p><b>Very common</b> (10% or more): Minor hemorrhage at any site (22%)</p>
<p><b>Common</b> (1% to 10%): Hemoglobin decreased, major hemorrhage at any site (including fatal outcomes)</p>
<p><b>Uncommon</b> (0.1% to 1%): Thrombocytopenia, anemia, hematoma</p>
<p><b>Rare</b> (less than 0.1%): INR increased </p>
<p><b>Postmarketing reports</b>: Catheter thrombosis, arteriovenous fistula, compartment syndrome<sup>[Ref]</sup></p><h3>Hypersensitivity</h3><p><b>Uncommon</b> (0.1% to 1%): Anaphylaxis (including fatal shock)<sup>[Ref]</sup></p><h3>Local</h3><p><b>Common</b> (1% to 10%): Access site hemorrhage, vessel puncture site hematoma (5 cm or less), vessel puncture site hematoma (greater than 5 cm), injection site pain</p>
<p><b>Rare</b> (less than 0.1%): Injection site reactions (i.e., injection site discomfort, injection site pain, puncture site reaction)<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Very common</b> (10% or more): Back pain</p>
<p><b>Common</b> (1% to 10%): Chest pain<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Common</b> (1% to 10%): Headache, insomnia</p>
<p><b>Rare</b> (less than 0.1%): Intracranial hemorrhage<sup>[Ref]</sup></p><h3>Ocular</h3><p><b>Rare</b> (less than 0.1%): Intraocular hemorrhage<sup>[Ref]</sup></p><h3>Other</h3><p><b>Rare</b> (less than 0.1%): Ear hemorrhage<sup>[Ref]</sup></p><h3>Psychiatric</h3><p><b>Common</b> (1% to 10%): Nervousness<sup>[Ref]</sup></p><div class="referenceList"><h4 id="refs">References</h4><p id="ref_1">1. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p><p id="ref_2">2. "Product Information. Bivalirudin (bivalirudin)." Fresenius Kabi USA, Lake Zurich, IL. </p><p id="ref_3">3. "Product Information. Angiomax (bivalirudin)" The Medicines Compny, Cambridge, MA. </p></div>
<div class="more-resources" id="moreResources">
<h2>More about Angiomax (bivalirudin)</h2>
<ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>Drug Interactions</li>
<li>Pricing &amp; Coupons</li>
<li>En Español</li>
<li>1 Review</li>
<li>Generic Availability</li>
<li>Drug class: thrombin inhibitors</li>
</ul>
<h3>Consumer resources</h3>
<ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Angiomax &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul>
<h3>Professional resources</h3>
<ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +1 more</li>
</ul>
<h3>Related treatment guides</h3>
<ul class="more-resources-list more-resources-list-conditions">
<li>Angina</li>
<li>Percutaneous Coronary Intervention</li>
</ul>
</div>
<h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p>
<p>Some side effects may not be reported. You may report them to the FDA.</p>
<p class="ddc-disclaimer-link">Medical Disclaimer</p>
<script>
function showRefs(refs) {
	if (!document.querySelectorAll) {
		return;
	}

	var referenceIds = refs ? refs.split(',') : [];
	var referenceTitle = referenceIds.length
		 ? "References relevant to chosen section <span class='ddc-text-size-small font-weight-normal'>(<a href='#refs' onclick='showRefs(\"\"); return false;'>Show all references</a>)</span>"
		 : "References";
	document.getElementById('refs').innerHTML = referenceTitle;

	// Show/hide reference items
	var referenceList = document.querySelectorAll('.referenceList p');
	referenceList.forEach(function(item) {
		var id = item.id.replace('ref_', '');
		if (!referenceIds.length || referenceIds.includes(id)) {
			item.style.display = 'block';
		}
		else {
			item.style.display = 'none';
		}
	});
}
</script>
</p><h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to bivalirudin: intravenous powder for injection, intravenous solution</i></p><h3>Cardiovascular</h3><p><b>Common</b> (1% to 10%): Atrial fibrillation, ventricular tachycardia, angina pectoris, bradycardia, hypertension, hypotension, chest pain</p><p><b>Rare</b> (less than 0.1%): Myocardial infarction, cardiac tamponade, pericardial hemorrhage, coronary artery thrombosis, coronary stent thrombosis (including reports with fatal outcome), arteriovenous fistula, catheter thrombosis, vascular pseudoaneurysm </p><p><b>Postmarketing reports</b>: Cardiac tamponade, ventricular fibrillation<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Uncommon</b> (0.1% to 1%): Epistaxis, hemoptysis, pharyngeal hemorrhage</p><p><b>Rare</b> (less than 0.1%): Pulmonary hemorrhage, dyspnea<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Uncommon</b> (0.1% to 1%): Rash, urticaria<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Common</b> (1% to 10%): Nausea, vomiting, dyspepsia</p><p><b>Uncommon</b> (0.1% to 1%): GI hemorrhage (i.e., hematemesis, melena, esophageal hemorrhage, anal hemorrhage), retroperitoneal hemorrhage, gingival hemorrhage</p><p><b>Rare</b> (less than 0.1%): Retroperitoneal hematoma<sup>[Ref]</sup></p><h3>Genitourinary</h3><p><b>Uncommon</b> (0.1% to 1%): Hematuria<sup>[Ref]</sup></p><h3>Hematologic</h3><p><b>Very common</b> (10% or more): Minor hemorrhage at any site (22%)</p><p><b>Common</b> (1% to 10%): Hemoglobin decreased, major hemorrhage at any site (including fatal outcomes)</p><p><b>Uncommon</b> (0.1% to 1%): Thrombocytopenia, anemia, hematoma</p><p><b>Rare</b> (less than 0.1%): INR increased </p><p><b>Postmarketing reports</b>: Catheter thrombosis, arteriovenous fistula, compartment syndrome<sup>[Ref]</sup></p><h3>Hypersensitivity</h3><p><b>Uncommon</b> (0.1% to 1%): Anaphylaxis (including fatal shock)<sup>[Ref]</sup></p><h3>Local</h3><p><b>Common</b> (1% to 10%): Access site hemorrhage, vessel puncture site hematoma (5 cm or less), vessel puncture site hematoma (greater than 5 cm), injection site pain</p><p><b>Rare</b> (less than 0.1%): Injection site reactions (i.e., injection site discomfort, injection site pain, puncture site reaction)<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Very common</b> (10% or more): Back pain</p><p><b>Common</b> (1% to 10%): Chest pain<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Common</b> (1% to 10%): Headache, insomnia</p><p><b>Rare</b> (less than 0.1%): Intracranial hemorrhage<sup>[Ref]</sup></p><h3>Ocular</h3><p><b>Rare</b> (less than 0.1%): Intraocular hemorrhage<sup>[Ref]</sup></p><h3>Other</h3><p><b>Rare</b> (less than 0.1%): Ear hemorrhage<sup>[Ref]</sup></p><h3>Psychiatric</h3><p><b>Common</b> (1% to 10%): Nervousness<sup>[Ref]</sup></p><p id="ref_1">1. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p><p id="ref_2">2. "Product Information. Bivalirudin (bivalirudin)." Fresenius Kabi USA, Lake Zurich, IL. </p><p id="ref_3">3. "Product Information. Angiomax (bivalirudin)" The Medicines Compny, Cambridge, MA. </p><h2>More about Angiomax (bivalirudin)</h2><ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>Drug Interactions</li>
<li>Pricing &amp; Coupons</li>
<li>En Español</li>
<li>1 Review</li>
<li>Generic Availability</li>
<li>Drug class: thrombin inhibitors</li>
</ul><h3>Consumer resources</h3><ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Angiomax &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul><h3>Professional resources</h3><ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +1 more</li>
</ul><h3>Related treatment guides</h3><ul class="more-resources-list more-resources-list-conditions">
<li>Angina</li>
<li>Percutaneous Coronary Intervention</li>
</ul><h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p><p>Some side effects may not be reported. You may report them to the FDA.</p><p class="ddc-disclaimer-link">Medical Disclaimer</p>